{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:35:51Z","timestamp":1793140551171,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacc.2025.03.530","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T10:02:43Z","timestamp":1746439363000},"page":"1774-1788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Disentangling the Impact of Adiposity From Insulin Resistance in Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"85","author":[{"given":"Yogesh N.V.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Hemnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Hassoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Rischard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika B.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serpil C.","family":"Erzurum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0156-6757","authenticated-orcid":false,"given":"J. Emanuel","family":"Finet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Jellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Mathai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Borlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.03.530_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","article-title":"The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.03.530_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","article-title":"Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial","volume":"4","author":"Haass","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib4","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jchf.2024.07.021","article-title":"Undiagnosed diabetes in heart failure with preserved ejection fraction","volume":"12","author":"Ostrominski","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ejhf.2403","article-title":"Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction","volume":"24","author":"Jackson","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib6","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/ejhf.3304","article-title":"Cardiovascular-kidney-metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril\/valsartan in PARAGON-HF","volume":"26","author":"Lassen","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib7","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.mayocp.2018.11.037","article-title":"Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"94","author":"Reddy","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2025.03.530_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib9","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ejhf.1788","article-title":"Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity","volume":"22","author":"Reddy","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013114","article-title":"Association of diabetes mellitus on cardiac remodeling, quality of life, and clinical outcomes in heart failure with reduced and preserved ejection fraction","volume":"8","author":"Yap","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.03.530_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2014.05.030","article-title":"Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study","volume":"64","author":"Lindman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.03.530_bib12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.116.024593","volume":"135","author":"Kristensen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.03.530_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2021.08.020","article-title":"Prevalence and prognostic implications of diabetes with cardiomyopathy in community-dwelling adults","volume":"78","author":"Segar","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.03.530_bib14","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.03.530_bib15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/CIRCULATIONAHA.116.025957","article-title":"The diabetic heart failure with preserved ejection fraction phenotype: is it real and is it worth targeting therapeutically?","volume":"135","author":"Lindman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.03.530_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.03.530_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.03.530_bib18","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.03.530_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jacc.2024.03.380","article-title":"Randomized trial of a selective aldose reductase inhibitor in patients with diabetic cardiomyopathy","volume":"84","author":"Januzzi","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.03.530_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41569-020-00465-5","article-title":"Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging","volume":"18","author":"Ng","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2025.03.530_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2022.05.038","article-title":"Clinical characteristics and transplant-free survival across the spectrum of pulmonary vascular disease","volume":"80","author":"Hemnes","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.03.530_bib22","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.03.530_bib23","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2025.03.530_bib24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/eurheartj\/ehad083","article-title":"Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox","volume":"44","author":"Butt","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.03.530_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","article-title":"Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis","volume":"13","author":"Ashwell","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.jacc.2025.03.530_bib26","article-title":"Comparative evaluation of waist-to-height ratio and BMI in predicting adverse cardiovascular outcome in people with diabetes: a systematic review","volume":"15","author":"Tewari","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jacc.2025.03.530_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.15051","article-title":"Body roundness index and all-cause mortality among US adults","volume":"7","author":"Zhang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.03.530_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacc.2016.05.043","article-title":"High-output heart failure: a 15-year experience","volume":"68","author":"Reddy","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.03.530_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ejhf.193","article-title":"Calculated plasma volume status and prognosis in chronic heart failure","volume":"17","author":"Ling","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib30","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/CIRCRESAHA.117.311737","article-title":"PVDOMICS: a multi-center study to improve understanding of pulmonary vascular disease through phenomics","volume":"121","author":"Hemnes","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2025.03.530_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006363","article-title":"Comprehensive diagnostic evaluation of cardiovascular physiology in patients with pulmonary vascular disease: insights from the PVDOMICS program","volume":"13","author":"Tang","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.03.530_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2337\/diaclin.33.2.97","article-title":"Standards of medical care in diabetes-2015 abridged for primary care providers","volume":"33","year":"2015","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.jacc.2025.03.530_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jchf.2018.03.003","article-title":"Hemodynamic correlates and diagnostic role of cardiopulmonary exercise testing in heart failure with preserved ejection fraction","volume":"6","author":"Reddy","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4172\/2161-1165.1000227","article-title":"Multicollinearity in regression analyses conducted in epidemiologic studies","volume":"6","author":"Vatcheva","year":"2016","journal-title":"Epidemiology (Sunnyvale)"},{"key":"10.1016\/j.jacc.2025.03.530_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1388-9842(02)00244-1","article-title":"Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation","volume":"5","author":"Rostagno","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2023.03.025","article-title":"Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction","volume":"379","author":"Fujimoto","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.03.530_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mayocp.2023.08.031","article-title":"Inorganic nitrite to amplify the benefits and tolerability of exercise training in heart failure with preserved ejection fraction: the INABLE-Training trial","volume":"99","author":"Borlaug","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2025.03.530_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf057","article-title":"Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.03.530_bib40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/ejhf.2563","article-title":"Sex and central obesity in heart failure with preserved ejection fraction","volume":"24","author":"Sorimachi","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.jacc.2025.03.530_bib41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ejhf.3447","article-title":"Metabolic dysfunction and incidence of heart failure subtypes among Black individuals: the Jackson Heart Study","volume":"27","author":"Kaze","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.03.530_bib43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ejhf.1621","article-title":"Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis","volume":"22","author":"Segar","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib44","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jchf.2023.06.031","article-title":"Interleukin-6 in patients with heart failure and preserved ejection fraction","volume":"11","author":"Alogna","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib45","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ejhf.2254","article-title":"Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction","volume":"23","author":"Sorimachi","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib46","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1093\/eurheartj\/ehac481","article-title":"Dapagliflozin for heart failure according to body mass index: the DELIVER trial","volume":"43","author":"Adamson","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.03.530_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ejhf.3092","article-title":"Obesity in heart failure with preserved ejection fraction: insights from the REDUCE LAP-HF II trial","volume":"26","author":"Litwin","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib48","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehae534","article-title":"Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction","volume":"45","author":"Reddy","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.03.530_bib49","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.123.065134","article-title":"Cardiac and metabolic effects of dapagliflozin in heart failure with preserved ejection fraction: the CAMEO-DAPA trial","volume":"148","author":"Borlaug","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.03.530_bib50","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2025.03.530_bib51","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.03.530_bib52","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jchf.2023.05.015","article-title":"Cardio-renal-metabolic overlap, outcomes, and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"11","author":"Ostrominski","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib53","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.03.530_bib54","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1172\/JCI81507","article-title":"Abdominal obesity: a marker of ectopic fat accumulation","volume":"125","author":"Smith","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2025.03.530_bib55","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.120.050941","article-title":"Association of baseline and longitudinal changes in body composition measures with risk of heart failure and myocardial infarction in type 2 diabetes: findings from the Look AHEAD trial","volume":"142","author":"Patel","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.03.530_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.3269","article-title":"Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: a pre-specified analysis of the DELIVER trial","author":"Lassen","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.03.530_bib57","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2025.03.530_bib58","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.03.530_bib59","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.03.530_bib60","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for Obesity Treatment and Diabetes Prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"issue":"10437","key":"10.1016\/j.jacc.2025.03.530_bib61","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.03.530_bib62","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/CIRCULATIONAHA.124.069479","article-title":"Effects of Dapagliflozin on body composition and its relation to hemodynamics in heart failure with preserved ejection fraction","volume":"149","author":"Naser","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.03.530_bib63","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.117.310920","article-title":"\u201cPound-years\u201d: effects on the heart of long-term exposure to obesity","volume":"120","author":"Joshi","year":"2017","journal-title":"Circ Res"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725060681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725060681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:23:18Z","timestamp":1778692998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725060681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":63,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0735109725060681"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.03.530","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disentangling the Impact of Adiposity From Insulin Resistance in Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.03.530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}